In Situ-Activated Phospholipid-Mimic Artemisinin Prodrug via Injectable Hydrogel Nano/Microsphere for Rheumatoid Arthritis Therapy
In situ-activated therapy is a decent option for localized diseases with improved efficacies and reduced side effects, which is heavily dependent on the local conversion or activation of bioinert components. In this work, we applied a phospholipid-mimic artemisinin prodrug (ARP) for preparing an inj...
Main Authors: | Yawei Du, Chao Li, Yu Zhang, Wei Xiong, Fei Wang, Juan Wang, Yingze Zhang, Lianfu Deng, Xinsong Li, Wei Chen, Wenguo Cui |
---|---|
Format: | Article |
Language: | English |
Published: |
American Association for the Advancement of Science (AAAS)
2022-01-01
|
Series: | Research |
Online Access: | https://spj.science.org/doi/10.34133/research.0003 |
Similar Items
-
Prodrug-based nanomedicines for rheumatoid arthritis
by: Pei Li, et al.
Published: (2024-01-01) -
Visualizable and Lubricating Hydrogel Microspheres Via NanoPOSS for Cartilage Regeneration
by: Yubin Yao, et al.
Published: (2023-05-01) -
In Situ Sustained Macrophage-Targeted Nanomicelle–Hydrogel Microspheres for Inhibiting Osteoarthritis
by: XiaoXiao Li, et al.
Published: (2023-01-01) -
Hydrogels for the treatment of rheumatoid arthritis
by: Jiafeng Yi, et al.
Published: (2022-10-01) -
Injectable hydrogel microspheres in cartilage repair
by: Feng Lin, et al.
Published: (2023-03-01)